Literature DB >> 11204439

Postnatal and pubertal skeletal changes contribute predominantly to the differences in peak bone density between C3H/HeJ and C57BL/6J mice.

C Richman1, S Kutilek, N Miyakoshi, A K Srivastava, W G Beamer, L R Donahue, C J Rosen, J E Wergedal, D J Baylink, S Mohan.   

Abstract

Previous studies have shown that 60-70% of variance in peak bone density is determined genetically. The higher the peak bone density, the less likely an individual is to eventually develop osteoporosis. Therefore, the amount of bone accrued during postnatal and pubertal growth is an important determining factor in the development of osteoporosis. We evaluated the contribution of skeletal changes before, during, and after puberty to the development of peak bone density in C3H/HeJ (C3H) and C57BL/6J (B6) mice. Volumetric bone density and geometric parameters at the middiaphysis of femora were measured by peripheral quantitative computed tomography (pQCT) from days 7 to 56. Additionally, biochemical markers of bone remodeling in serum and bone extracts were quantified. Both B6 and C3H mice showed similar body and femoral weights. B6 mice had greater middiaphyseal total bone area and thinner cortices than did C3H mice. Within strains, males had thicker cortices than did females. C3H mice accumulated more minerals throughout the study, with the most rapid accumulation occurring postnatally (days 7-23) and during pubertal maturation (days 23-31). C3H mice had higher volumetric bone density as early as day 7, compared with B6 mice. Higher serum insulin-like growth factor I (IGF-I) was present in C3H mice postnatally at day 7 and day 14. Until day 31, B6 male and female mice had significantly higher serum osteocalcin than C3H male and female mice, respectively. Alkaline phosphatase (ALP) was found to be significantly higher in the bone extract of C3H mice compared with B6 mice at day 14. These data are consistent with and support the hypothesis that the greater amount of bone accrued during postnatal and pubertal growth in C3H mice compared with B6 mice may be caused by increased cortical thickness, increased endosteal bone formation, and decreased endosteal bone resorption.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11204439     DOI: 10.1359/jbmr.2001.16.2.386

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  38 in total

Review 1.  The role of circulating IGF-I: lessons from human and animal models.

Authors:  Shoshana Yakar; Yiping Wu; Jennifer Setser; Clifford J Rosen
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

2.  Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms.

Authors:  Subburaman Mohan; Charmaine Richman; Rongqing Guo; Yousef Amaar; Leah Rea Donahue; Jon Wergedal; David J Baylink
Journal:  Endocrinology       Date:  2003-03       Impact factor: 4.736

3.  Serum xylosyltransferase 1 level increases during early posttraumatic osteoarthritis in mice with high bone forming potential.

Authors:  Sarah Y McCoy; Kerry A Falgowski; Padma P Srinivasan; William R Thompson; Erica M Selva; Catherine B Kirn-Safran
Journal:  Bone       Date:  2011-12-02       Impact factor: 4.398

4.  Rare coding variants in ALPL are associated with low serum alkaline phosphatase and low bone mineral density.

Authors:  Carrie M Nielson; Joseph M Zmuda; Amy S Carlos; Wendy J Wagoner; Emily A Larson; Eric S Orwoll; Robert F Klein
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

Review 5.  Role and Mechanisms of Actions of Thyroid Hormone on the Skeletal Development.

Authors:  Ha-Young Kim; Subburaman Mohan
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

6.  IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation.

Authors:  Yuhao Gao; Francesco Grassi; Michaela Robbie Ryan; Masakazu Terauchi; Karen Page; Xiaoying Yang; M Neale Weitzmann; Roberto Pacifici
Journal:  J Clin Invest       Date:  2006-12-14       Impact factor: 14.808

7.  Circulating levels of IGF-1 directly regulate bone growth and density.

Authors:  Shoshana Yakar; Clifford J Rosen; Wesley G Beamer; Cheryl L Ackert-Bicknell; Yiping Wu; Jun-Li Liu; Guck T Ooi; Jennifer Setser; Jan Frystyk; Yves R Boisclair; Derek LeRoith
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

8.  Long-term experiment to study the development, interaction, and influencing factors of DEXA parameters.

Authors:  Helmut Fuchs; Christine Gau; Wolfgang Hans; Valerie Gailus-Durner; Martin Hrabě de Angelis
Journal:  Mamm Genome       Date:  2013-10-06       Impact factor: 2.957

9.  Prepubertal OVX increases IGF-I expression and bone accretion in C57BL/6J mice.

Authors:  Kristen E Govoni; Jon E Wergedal; Robert B Chadwick; Apurva K Srivastava; Subburaman Mohan
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-23       Impact factor: 4.310

10.  Fourier transform infrared imaging microspectroscopy and tissue-level mechanical testing reveal intraspecies variation in mouse bone mineral and matrix composition.

Authors:  Hayden-William Courtland; Philip Nasser; Andrew B Goldstone; Lyudmila Spevak; Adele L Boskey; Karl J Jepsen
Journal:  Calcif Tissue Int       Date:  2008-10-15       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.